Prefer a chat interface with context about you and your work?
Tumor fraction in cell-free DNA as a biomarker in prostate cancer
BACKGROUND. Tumor content in circulating cell-free DNA (cfDNA) is a promising biomarker, but longitudinal dynamics of tumor-derived and nonātumor-derived cfDNA through multiple courses of therapy have not been well described.